Generate a tailored SOP for Dr. Paul Stabach. Improve your application with a focused, well-structured draft.
Paul Stabach is a Research Associate and Lab Manager with 30 years of experience in molecular and cellular biology, having worked at prestigious institutions including Yale, MIT, and Baylor College of Medicine. His current research focuses on the design and implementation of novel enzyme biologics to treat debilitating pathologies associated with enzyme deficiencies, initially achieving success in the Braddock lab with a rare disease characterized by lethal vascular calcifications related to ENPP1 deficiency, known as 'Generalized Arterial Calcification of Infancy' (GACI). He has published findings on improving the potency and longevity of blood-based enzyme biologics. His ongoing work involves engineering new enzyme treatments targeting the aberrant formation of neutrophil extracellular traps associated with conditions like lupus, acute respiratory distress syndrome related to COVID-19, and cancer metastasis. Stabach's broad expertise encompasses various medical research interests, particularly in anti-neutrophil cytoplasmic antibody-associated vasculitis and chronic kidney disease.
Yale School of Medicine • New Haven, CT
Responsible for management and research within the lab, focusing on biological enzyme treatments and collaborating with various academic institutions.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.